Search - tctmd.com

Displaying 1 - 20 of 86

Sort: Relevancy | Date

Lasers a Valuable Tool to Retrieve Embedded IVC Filters: Multicenter Study

News Daily News

Lasers a Valuable Tool to Retrieve Embedded IVC Filters: Multicenter Study

December 30, 2022

OSCAR Supports Rivaroxaban for Secondary VTE Prevention in Cancer

News Daily News

OSCAR Supports Rivaroxaban for Secondary VTE Prevention in Cancer

December 16, 2022

ACS Care in Older Patients Entails Unique Risks, Shifting Goals, Says AHA

News Daily News

ACS Care in Older Patients Entails Unique Risks, Shifting Goals, Says AHA

December 16, 2022

Does BEST-CLI Settle the Surgery vs Endovascular Question for CLTI?

News Features

Does BEST-CLI Settle the Surgery vs Endovascular Question for CLTI?

December 02, 2022

Don’t Skimp on Anticoagulation in Isolated Distal DVT: RIDTS

News Daily News

Don’t Skimp on Anticoagulation in Isolated Distal DVT: RIDTS

December 01, 2022

‘Agnostic’ EHR Alerts Boost VTE Prophylaxis in Hospitals and Postdischarge

News Conference News AHA 2022

‘Agnostic’ EHR Alerts Boost VTE Prophylaxis in Hospitals and Postdischarge

November 11, 2022

STRONG-HF: Rapid Uptitration of GDMT After Acute HF Pays Dividends

News Conference News AHA 2022

STRONG-HF: Rapid Uptitration of GDMT After Acute HF Pays Dividends

November 07, 2022

Pemafibrate Fails to Lower CVD Risk in Patients With High Triglycerides: PROMINENT

News Conference News AHA 2022

Pemafibrate Fails to Lower CVD Risk in Patients With High Triglycerides: PROMINENT

Michael O'Riordan

November 05, 2022

COVID Vaccine Thrombosis, Thrombocytopenia Risks Clarified in International Study

News Daily News

COVID Vaccine Thrombosis, Thrombocytopenia Risks Clarified in International Study

October 28, 2022

Study Affirms Higher CVD, Mortality Risks Among COVID-Positive Patients

News Daily News

Study Affirms Higher CVD, Mortality Risks Among COVID-Positive Patients

October 26, 2022

Apixaban Tops Rivaroxaban in AF Patients With Valve Disease, Claims Data Suggest

News Daily News

Apixaban Tops Rivaroxaban in AF Patients With Valve Disease, Claims Data Suggest

Michael O'Riordan

October 20, 2022

Hints of Benefit With Catheter-Directed Thrombolysis in Intermediate/High-Risk PE

News Daily News

Hints of Benefit With Catheter-Directed Thrombolysis in Intermediate/High-Risk PE

October 19, 2022

Heart Transplantation After Circulatory Death Gives ‘Encouraging’ Results

News Daily News

Heart Transplantation After Circulatory Death Gives ‘Encouraging’ Results

Yael L. Maxwell

September 30, 2022

Initiative Lowers Unnecessary Aspirin Use in Warfarin Users

News Daily News

Initiative Lowers Unnecessary Aspirin Use in Warfarin Users

September 26, 2022

CCTA in Patients With Prior CABG Cuts Complications of Invasive Angio: BYPASS-CTCA

News Conference News TCT 2022

CCTA in Patients With Prior CABG Cuts Complications of Invasive Angio: BYPASS-CTCA

Yael L. Maxwell

September 21, 2022

How Do I Choose DVTs to Intervene Upon?

Presentation TCT 2022

How Do I Choose DVTs to Intervene Upon?

Presenter: Jon George

September 19, 2022

Iliocaval Stenting and Reconstructions With Extreme Case Examples

Presentation TCT 2022

Iliocaval Stenting and Reconstructions With Extreme Case Examples

Presenter: S. Jay Mathews

September 19, 2022

Deep Venous Disease and Optimal DVT Intervention: State-of-the-Art Stenting, Valves, Imaging, and Future Directions

Presentation TCT 2022

Deep Venous Disease and Optimal DVT Intervention: State-of-the-Art Stenting, Valves, Imaging, and Future Directions

Presenter: Robert Lookstein

September 19, 2022

State-of-the-Art Lecture: Future Device Therapies in PE

Presentation TCT 2022

State-of-the-Art Lecture: Future Device Therapies in PE

Presenter: Robert Lookstein

September 19, 2022

Intermediate-Risk PE Case (NewYork-Presbyterian/Columbia University Irving Medical Center): Case Conclusion

Presentation TCT 2022

Intermediate-Risk PE Case (NewYork-Presbyterian/Columbia University Irving Medical Center): Case Conclusion

Presenter: Sanjum Sethi

September 19, 2022

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.